Troubles will delay successor to Claritin
Article Abstract:
Schering-Plough Corp. has had its shares downgraded by analysts after the firm announced that regulators detected problems at manufacturing plants that would delay introduction or a successor to Claritin, the company's flagship product.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Fen-phen costs rise for drug company
Article Abstract:
American Home Products Corp. has promoted Robert Essner, its top drug official, to president and COO, but the company's stock fell after the company announced it would need more than $4.7 billion to settle claims relating to fen-phen.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
U.S. GlaxoSmithKline unit is losing one copresident
Article Abstract:
George J. Morrow has resigned as copresident of GlaxoSmithKline PLC's United States pharmaceutical business. David Stout, the other copresident will take over the entire $11 billion U.S. business.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Genesis obtains reprieve on debt. Allegheny seeks to change its accounting firm
- Abstracts: Father Divine's hotel is sold. Rising room rates, falling stock. Hotel to get third name within year
- Abstracts: Two will say no to PhilEx merger. Philex board accepts most of sale offer. PhilEx to settle class-action suit for $2.8 million
- Abstracts: Hercules looks to sell BetzDearborn. Hercules taps ex-CEO of Union Carbide. Hercules chemical firm puts out 'for sale' sign
- Abstracts: Pa. helps company to add tech jobs. Amazon president hired by area firm. VerticalNet's last-period deficit widens